¼¼°èÀÇ °æÇÇ ¸ð´ÏÅÍ ½ÃÀå
Transcutaneous Monitors
»óǰÄÚµå : 1798282
¸®¼­Ä¡»ç : Global Industry Analysts, Inc.
¹ßÇàÀÏ : 2025³â 08¿ù
ÆäÀÌÁö Á¤º¸ : ¿µ¹® 291 Pages
 ¶óÀ̼±½º & °¡°Ý (ºÎ°¡¼¼ º°µµ)
US $ 5,850 £Ü 8,233,000
PDF & Excel (Single User License) help
PDF & Excel º¸°í¼­¸¦ 1¸í¸¸ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. ÆÄÀÏ ³» ÅØ½ºÆ®ÀÇ º¹»ç ¹× ºÙ¿©³Ö±â´Â °¡´ÉÇÏÁö¸¸, Ç¥/±×·¡ÇÁ µîÀº º¹»çÇÒ ¼ö ¾ø½À´Ï´Ù. Àμâ´Â 1ȸ °¡´ÉÇϸç, Àμ⹰ÀÇ ÀÌ¿ë¹üÀ§´Â ÆÄÀÏ ÀÌ¿ë¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.
US $ 17,550 £Ü 24,701,000
PDF & Excel (Global License to Company and its Fully-owned Subsidiaries) help
PDF & Excel º¸°í¼­¸¦ µ¿ÀÏ ±â¾÷ ¹× 100% ÀÚȸ»çÀÇ ¸ðµç ºÐÀÌ ÀÌ¿ëÇÏ½Ç ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμâ´Â 1Àδç 1ȸ °¡´ÉÇϸç, Àμ⹰ÀÇ ÀÌ¿ë¹üÀ§´Â ÆÄÀÏ ÀÌ¿ë¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.


Çѱ۸ñÂ÷

¼¼°èÀÇ °æÇÇ ¸ð´ÏÅÍ ½ÃÀåÀº 2030³â±îÁö 3¾ï 4,650¸¸ ´Þ·¯¿¡ ´ÞÇÒ Àü¸Á

2024³â¿¡ 2¾ï 5,390¸¸ ´Þ·¯·Î ÃßÁ¤µÇ´Â ¼¼°èÀÇ °æÇÇ ¸ð´ÏÅÍ ½ÃÀåÀº 2024-2030³â¿¡ CAGR 5.3%·Î ¼ºÀåÇϸç, 2030³â¿¡´Â 3¾ï 4,650¸¸ ´Þ·¯¿¡ ´ÞÇÒ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù. ÀÌ ¸®Æ÷Æ®¿¡¼­ ºÐ¼®ÇÑ ºÎ¹®ÀÇ ÇϳªÀΠâ»ó Ä¡À¯ ¾ÖÇø®ÄÉÀ̼ÇÀº CAGR 6.5%¸¦ ±â·ÏÇϸç, ºÐ¼® ±â°£ Á¾·á½Ã¿¡´Â 1¾ï 4,610¸¸ ´Þ·¯¿¡ ´ÞÇÒ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù. Ç÷¾×°¡½º ¸ð´ÏÅ͸µ ¾ÖÇø®ÄÉÀÌ¼Ç ºÎ¹®ÀÇ ¼ºÀå·üÀº ºÐ¼® ±â°£ Áß CAGR 3.6%·Î ÃßÁ¤µË´Ï´Ù.

¹Ì±¹ ½ÃÀåÀº 6,920¸¸ ´Þ·¯·Î ÃßÁ¤, Áß±¹Àº CAGR 8.6%·Î ¼ºÀå ¿¹Ãø

¹Ì±¹ÀÇ °æÇÇ ¸ð´ÏÅÍ ½ÃÀåÀº 2024³â¿¡ 6,920¸¸ ´Þ·¯·Î ÃßÁ¤µË´Ï´Ù. ¼¼°è 2À§ÀÇ °æÁ¦´ë±¹ÀÎ Áß±¹Àº ºÐ¼® ±â°£ 2024-2030³â¿¡ CAGR 8.6%·Î ÃßÀÌÇϸç, 2030³â¿¡´Â ¿¹Ãø ½ÃÀå ±Ô¸ð 7,010¸¸ ´Þ·¯¿¡ ´ÞÇÒ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù. ±âŸ ÁÖ¸ñÇÒ ¸¸ÇÑ Áö¿ªº° ½ÃÀåÀ¸·Î´Â ÀϺ»°ú ij³ª´Ù°¡ ÀÖÀ¸¸ç, ºÐ¼® ±â°£ Áß CAGRÀº °¢°¢ 2.5%¿Í 5.3%·Î ¿¹ÃøµË´Ï´Ù. À¯·´¿¡¼­´Â µ¶ÀÏÀÌ CAGR ¾à 3.5%·Î ¼ºÀåÇÒ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù.

¼¼°èÀÇ °æÇÇ ¸ð´ÏÅÍ ½ÃÀå - ÁÖ¿ä µ¿Çâ°ú ÃËÁø¿äÀÎ Á¤¸®

°æÇÇ ¸ð´ÏÅÍ´Â Ä¡·á¿¡¼­ ¾î¶² ¿ªÇÒÀ» Çϴ°¡?

°æÇÇ ¸ð´ÏÅÍ´Â °¡¿­ ¼¾¼­ Àü±ØÀ» »ç¿ëÇÏ¿© ÇǺθ¦ ÅëÇØ »ý¸®Àû ¸Å°³º¯¼ö(ÁÖ·Î »ê¼Ò(PtcO2), ÀÌ»êȭź¼Ò(PtcCO2), ¶§·Î´Â Æ÷µµ´ç)¸¦ ÃøÁ¤ÇÕ´Ï´Ù. ½Å»ý¾Æ, È£Èí±â ȯÀÚ, ÁßÁõ ȯÀÚ¿¡¼­ Áö¼ÓÀûÀÎ ½Ç½Ã°£ ÃßÀûÀÌ °¡´ÉÇϸç, µ¿¸Æ õÀÚ¸¦ ÀÚÁÖ ½ÃÇàÇÒ Çʿ伺À» ÁÙÀÏ ¼ö ÀÖ½À´Ï´Ù. Á¶±â °³ÀÔ°ú ÁßȯÀÚ½Ç ¿öÅ©Ç÷ο쿡 À־´Â Ãß¼¼¸¦ ¹ß°ßÇÏ°í ¾ÇÈ­¸¦ ¹Ì¸® ¿¹ÃøÇÏ´Â ´É·ÂÀÌ ÇʼöÀûÀÔ´Ï´Ù.

¿þ¾î·¯ºí ÇǺΠ¸ð´ÏÅ͸µÀº ¾î¶² ±â¼ú Çõ½ÅÀ» ÅëÇØ ¹ßÀüÇØ ¿Ô´Â°¡?

»õ·Î¿î Á¢ÂøÁ¦¿Í ÇÏÀ̵å·Î°Ö ¼¾¼­´Â ½Å»ý¾ÆÀÇ ÇǺΠÀÚ±ØÀ» ÃÖ¼ÒÈ­Çϸ鼭 ¸çÄ¥°£ Àå±â°£ Âø¿ëÇÒ ¼ö ÀÖµµ·Ï Çß½À´Ï´Ù. ¼ÒÇüÈ­µÈ ÀüÀÚ±â±â´Â Bluetooth Low Energy¸¦ ÅëÇÑ ¹«¼±Àü¼ÛÀ» °¡´ÉÇÏ°Ô ÇÏ¿© ÀüÀÚÀǹ«±â·Ï(EMR)°úÀÇ ÅëÇÕÀ» °¡´ÉÇÏ°Ô Çß½À´Ï´Ù. ¸ÖƼ¸ð´Þ ¼¾¼­´Â °æÇÇ ¹× ÆÞ½º ¿Á½Ã¸ÞÆ®¸®¸¦ °áÇÕÇÏ¿© °ü·ù ¶Ç´Â °æÇÇÀû ¾à¹° ¼öÁØÀ» ÃßÁ¤ÇÕ´Ï´Ù. AI ±â¹Ý ¾Ë°í¸®ÁòÀÌ ¿Âµµ ¼³Á¤À» ÀÚµ¿ Á¶Á¤Çϰí ÇǺΠµÎ²²¸¦ °í·ÁÇÏ¿© ´Ù¾çÇÑ È¯ÀÚ Áý´Ü¿¡¼­ Á¤È®µµ¸¦ Çâ»ó½Ãŵ´Ï´Ù.

°æÇÇ ÃøÁ¤À¸·Î °¡Àå Å« ÀÌÀÍÀ» ¾ò´Â »ç¶÷Àº ´©±¸Àΰ¡?

½Å»ý¾Æ ÁßȯÀڽǿ¡¼­´Â °æÇÇ ¸ð´ÏÅ͸¦ ÅëÇØ ¹Ì¼÷¾ÆÀÇ Æó ±â´ÉÀ» ÃßÀûÇÏ¿© ħ½ÀÀû »ùÇøµÀ» ÁÙÀ̰í ÀÖ½À´Ï´Ù. È£Èí±â º´µ¿¿¡¼­´Â Áö¼ÓÀûÀÎ CO2 µ¿Çâ µ¥ÀÌÅÍ·Î COPD ¹× ÀΰøÈ£Èí±â ÀÌÅ»À» °ü¸®Çϰí ÀÖ½À´Ï´Ù. ¿Ü·¡ ȯÀÚ´Â ÀçÅà ´ç´¢º´ Ä¡·á Áß °æÇÇÀû Ç÷´çÃøÁ¤±â¸¦ »ç¿ëÇϰí ÀÖ½À´Ï´Ù. ¼ö¼ú½ÇÀ̳ª ÁøÁ¤ ½Ã¼³¿¡¼­´Â °¡½º ±³È¯ÀÇ ÃßÀ̸¦ ¸ð´ÏÅ͸µÇÏ¿© ÀΰøÈ£ÈíÀÇ ÁöħÀ¸·Î »ï°í ÀÖ½À´Ï´Ù. ¼ö¸é Ŭ¸®´Ð¿¡¼­´Â Áý¿¡¼­ ¼ö¸é¹«È£ÈíÁõ Áø´ÜÀ» À§ÇØ »ç¿ëµÇ°í ÀÖ½À´Ï´Ù.

ÀÓ»ó µµÀÔÀ» ÃËÁøÇÏ´Â ¿äÀÎÀº ¹«¾ùÀΰ¡?

°æÇÇ ¸ð´ÏÅÍ ½ÃÀåÀÇ ¼ºÀåÀ» À̲ô´Â ¿äÀÎÀ¸·Î´Â ¸¸¼º È£Èí±â ¹× ´ë»ç¼º ÁúȯÀÇ À¯º´·ü Áõ°¡, ºñħ½ÀÀû Ä¡·áÀÇ º£½ºÆ® ÇÁ·¢Æ¼½º¿¡ ´ëÇÑ ¼±È£, ÀçÅà ¹× ÀÔ¿ø ȯ°æ¿¡¼­ÀÇ Áö¼ÓÀûÀÎ ¸ð´ÏÅ͸µ¿¡ ´ëÇÑ ¼ö¿ä µîÀÌ ÀÖ½À´Ï´Ù. ±â¼úÀû ¼ÒÇüÈ­, ÇǺΠÁ¢ÂøÁ¦ÀÇ ¹ßÀü, ¹«¼± ÅëÇÕÀ» ÅëÇØ POC(Point-Of-Care)ÀÇ ¹èÄ¡°¡ °¡´ÉÇØÁ³½À´Ï´Ù. Áö¼ÓÀûÀÎ ¸ð´ÏÅ͸µ¿¡ ´ëÇÑ ±ÔÁ¦ ¼ö¿ë ¹× »óȯ ÇÁ·¹ÀÓ¿öÅ©°¡ º´¿ø¿¡¼­ÀÇ ±¸¸Å¸¦ ÃËÁøÇÕ´Ï´Ù. ¿ø°Ý ȯÀÚ ¸ð´ÏÅ͸µ°ú ¿ø°Ý ICUÀÇ È®ÀåÀ» °­Á¶ÇÏ´Â ÆÒµ¥¹ÍÀÇ °æÇèÀº äÅÃÀÇ ¸ð¸àÅÒÀ» ´õ¿í °ø°íÈ÷ÇÒ °ÍÀÔ´Ï´Ù.

ºÎ¹®

¾ÖÇø®ÄÉÀ̼Ç(â»ó Ä¡À¯ ¾ÖÇø®ÄÉÀ̼Ç, Ç÷¾×°¡½º ¸ð´ÏÅ͸µ ¾ÖÇø®ÄÉÀ̼Ç, È£Èí±â ÄÉ¾î ¾ÖÇø®ÄÉÀ̼Ç, ¼ö¸é Áø´Ü ¾ÖÇø®ÄÉÀ̼Ç, ±âŸ ¾ÖÇø®ÄÉÀ̼Ç), ÃÖÁ¾»ç¿ëÀÚ(º´¿ø ÃÖÁ¾»ç¿ëÀÚ, ¿Ü·¡ ¼ö¼ú ¼¾ÅÍ ÃÖÁ¾»ç¿ëÀÚ, Àü¹® Ŭ¸®´Ð ÃÖÁ¾»ç¿ëÀÚ)

Á¶»ç ´ë»ó ±â¾÷ÀÇ ¿¹

AI ÅëÇÕ

Global Industry Analysts´Â À¯È¿ÇÑ Àü¹®°¡ ÄÁÅÙÃ÷¿Í AI Åø¿¡ ÀÇÇØ ½ÃÀå Á¤º¸¿Í °æÀï Á¤º¸¸¦ º¯ÇõÇϰí ÀÖ½À´Ï´Ù.

Global Industry Analysts´Â ÀϹÝÀûÀÎ LLM³ª ¾÷°èº° SLM Äõ¸®¿¡ µû¸£´Â ´ë½Å¿¡, ºñµð¿À ±â·Ï, ºí·Î±×, °Ë»ö ¿£Áø Á¶»ç, ´ë·® ±â¾÷, Á¦Ç°/¼­ºñ½º, ½ÃÀå µ¥ÀÌÅÍ µî, Àü ¼¼°è Àü¹®°¡·ÎºÎÅÍ ¼öÁýÇÑ ÄÁÅÙÃ÷ ¸®Æ÷ÁöÅ丮¸¦ ±¸ÃàÇß½À´Ï´Ù.

°ü¼¼ ¿µÇâ °è¼ö

Global Industry Analysts´Â º»»ç ¼ÒÀçÁö, Á¦Á¶°ÅÁ¡, ¼öÃâÀÔ(¿ÏÁ¦Ç° ¹× OEM)À» ±âÁØÀ¸·Î ±â¾÷ÀÇ °æÀï·Â º¯È­¸¦ ¿¹ÃøÇß½À´Ï´Ù. ÀÌ·¯ÇÑ º¹ÀâÇÏ°í ´Ù¸éÀûÀÎ ½ÃÀå ¿ªÇÐÀº ¼öÀÔ¿ø°¡(COGS) Áõ°¡, ¼öÀͼº Ç϶ô, °ø±Þ¸Á ÀçÆí µî ¹Ì½ÃÀû, °Å½ÃÀû ½ÃÀå ¿ªÇÐ Áß¿¡¼­µµ ƯÈ÷ °æÀï»çµé¿¡°Ô ¿µÇâÀ» ¹ÌÄ¥ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù.

¸ñÂ÷

Á¦1Àå Á¶»ç ¹æ¹ý

Á¦2Àå °³¿ä

Á¦3Àå ½ÃÀå ºÐ¼®

Á¦4Àå °æÀï

KSA
¿µ¹® ¸ñÂ÷

¿µ¹®¸ñÂ÷

Global Transcutaneous Monitors Market to Reach US$346.5 Million by 2030

The global market for Transcutaneous Monitors estimated at US$253.9 Million in the year 2024, is expected to reach US$346.5 Million by 2030, growing at a CAGR of 5.3% over the analysis period 2024-2030. Wound Healing Application, one of the segments analyzed in the report, is expected to record a 6.5% CAGR and reach US$146.1 Million by the end of the analysis period. Growth in the Blood Gas Monitoring Application segment is estimated at 3.6% CAGR over the analysis period.

The U.S. Market is Estimated at US$69.2 Million While China is Forecast to Grow at 8.6% CAGR

The Transcutaneous Monitors market in the U.S. is estimated at US$69.2 Million in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$70.1 Million by the year 2030 trailing a CAGR of 8.6% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 2.5% and 5.3% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 3.5% CAGR.

Global Transcutaneous Monitor Market - Key Trends & Drivers Summarized

What Role Do Transcutaneous Monitors Serve in Care?

Transcutaneous monitors measure physiological parameters-typically oxygen (PtcO2), carbon dioxide (PtcCO2), and sometimes glucose-through the skin using heated-sensor electrodes. They offer continuous, real-time tracking in neonates, respiratory patients, and critical care cases, reducing the need for frequent arterial punctures. The ability to spot trends and pre-empt deterioration is vital for early intervention and ICU workflows.

What Innovations Have Advanced Wearable Skin Monitoring?

New adhesives and hydrogel sensors allow extended wear for several days with minimal skin irritation in neonates. Miniaturized electronics enable wireless transmission via Bluetooth Low Energy, integrating with electronic medical records (EMR). Multimodal sensors now combine transcutaneous and pulse oximetry to estimate perfusion or transdermal drug levels. AI-driven algorithms auto-calibrate temperature settings and account for skin thickness, improving accuracy in diverse patient populations.

Who Gains Most from Transcutaneous Measurement?

Neonatal intensive care units use transcutaneous monitors to track lung function in premature infants, reducing invasive sampling. Respiratory wards manage COPD and ventilator weaning with continuous CO2 trend data. Ambulatory patients use transcutaneous glucose monitors during home-based diabetes care. Operating rooms and procedural sedation providers monitor gas exchange trends to guide ventilation. Sleep clinics deploy them for at-home sleep apnea diagnostics.

What Is Propelling Their Clinical Adoption?

The growth in the transcutaneous monitors market is driven by rising prevalence of chronic respiratory and metabolic diseases, devotion to non-invasive care best practices, and demand for continuous monitoring at home and inpatient settings. Technological miniaturization, skin-adhesive advancements, and wireless integration enable point-of-care deployment. Regulatory acceptance and reimbursement frameworks for continuous monitoring encourage hospital purchase. Pandemic experiences highlighting remote patient monitoring and teleICU expansion further solidify adoption momentum.

SCOPE OF STUDY:

The report analyzes the Transcutaneous Monitors market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:

Application (Wound Healing Application, Blood Gas Monitoring Application, Respiratory Care Application, Sleep Diagnostics Application, Other Applications); End-User (Hospitals End-User, Ambulatory Surgery Centers End-User, Specialty Clinics End-User)

Geographic Regions/Countries:

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; Spain; Russia; and Rest of Europe); Asia-Pacific (Australia; India; South Korea; and Rest of Asia-Pacific); Latin America (Argentina; Brazil; Mexico; and Rest of Latin America); Middle East (Iran; Israel; Saudi Arabia; United Arab Emirates; and Rest of Middle East); and Africa.

Select Competitors (Total 48 Featured) -

AI INTEGRATIONS

We're transforming market and competitive intelligence with validated expert content and AI tools.

Instead of following the general norm of querying LLMs and Industry-specific SLMs, we built repositories of content curated from domain experts worldwide including video transcripts, blogs, search engines research, and massive amounts of enterprise, product/service, and market data.

TARIFF IMPACT FACTOR

Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by increasing the Cost of Goods Sold (COGS), reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

III. MARKET ANALYSIS

IV. COMPETITION

(ÁÖ)±Û·Î¹úÀÎÆ÷¸ÞÀÌ¼Ç 02-2025-2992 kr-info@giikorea.co.kr
¨Ï Copyright Global Information, Inc. All rights reserved.
PC¹öÀü º¸±â